MENU
+Compare
CHE
Stock ticker: NYSE
AS OF
May 22, 04:59 PM (EDT)
Price
$560.61
Change
-$10.62 (-1.86%)
Capitalization
9.7B

CHE stock forecast, quote, news & analysis

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value... Show more

CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for CHE with price predictions
May 21, 2025

CHE in downward trend: 10-day moving average broke below 50-day moving average on April 21, 2025

The 10-day moving average for CHE crossed bearishly below the 50-day moving average on April 21, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on May 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CHE as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CHE moved below its 50-day moving average on April 16, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CHE entered a downward trend on May 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CHE just turned positive on May 16, 2025. Looking at past instances where CHE's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .

CHE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.741) is normal, around the industry mean (4.650). P/E Ratio (35.730) is within average values for comparable stocks, (71.885). CHE's Projected Growth (PEG Ratio) (2.721) is slightly higher than the industry average of (1.595). CHE has a moderately low Dividend Yield (0.002) as compared to the industry average of (0.025). P/S Ratio (4.301) is also within normal values, averaging (9.268).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

CHE paid dividends on March 14, 2025

Chemed Corp CHE Stock Dividends
А dividend of $0.50 per share was paid with a record date of March 14, 2025, and an ex-dividend date of February 24, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 4.28B. The market cap for tickers in the group ranges from 1.86K to 88.21B. HCA holds the highest valuation in this group at 88.21B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -2%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 20%. KJFI experienced the highest price growth at 34%, while GBCS experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -19%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 58
Price Growth Rating: 55
SMR Rating: 100
Profit Risk Rating: 79
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a holding medical company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
255 East Fifth Street
Phone
+1 513 762-6690
Employees
15087
Web
https://www.chemed.com